IMCC (IM Cannabis) Total Equity: $-3.74 Mil (As of Mar. 2026)


IMCC IM Cannabis Corp IMCC
36 GF Score
Price $0.14
GF Value $1.39
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is IM Cannabis Total Equity?

IM Cannabis IMCC -10.70% 36 Total Equity is $-3.74 Mil as of Mar. 2026. GuruFocus rates IMCC with a GF Score™ of 36/100 and a GF Value™ of $1.39 (Possible Value Trap). The stock has 5 warning signs investors should review.

IM Cannabis's total equity for the quarter that ended in Mar. 2026 was $-3.74 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


IM Cannabis Total Equity Historical Data

* Premium members only.

The historical data trend for IM Cannabis's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IM Cannabis Total Equity Chart

IM Cannabis Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 160.11 17.52 10.21 2.21 -2.62

IM Cannabis Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.21 2.21 2.97 -2.62 -3.74
IMCC
36GF Score
IM Cannabis Corp IMCC
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IM Cannabis Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

IM Cannabis's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=23.005-25.626
=-2.62

IM Cannabis's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=17.275-21.009
=-3.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-3.74 Mil mean?
IM Cannabis (IMCC) has a Total Equity of $-3.74 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for IM Cannabis and its competitors.
Is IM Cannabis' Total Equity too high?
IM Cannabis' current Total Equity is $-3.74 Mil. Overall, IM Cannabis has a GF Score™ of 36/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IM Cannabis' Total Equity compare to CPMD and SKYI?
IM Cannabis' Total Equity of $-3.74 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for IM Cannabis and its competitors. IM Cannabis's current Total Equity is $-3.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IM Cannabis stock overvalued right now?
Based on GuruFocus' analysis, IM Cannabis (IMCC) is currently considered Possible Value Trap. The stock's GF Value™ is $1.39, compared to a current price of $0.14 — trading 89.8% below its estimated fair value. The current Total Equity is $-3.74 Mil. IM Cannabis' overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For IM Cannabis (IMCC), the current Total Equity is $-3.74 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IM Cannabis (IMCC) Overvalued in 2026?

Based on GuruFocus' analysis, IM Cannabis stock appears to be undervalued. The current stock price of $0.14 is trading 89.8% below its estimated GF Value™ of $1.39. GuruFocus considers IM Cannabis to be Possible Value Trap.

Key valuation signals for IMCC:

  • Total Equity: $-3.74 Mil
  • GF Value™: $1.39 vs. price of $0.14 (89.8% below fair value)
  • GF Score™: 36/100 with 5 warning signs

No single metric tells the full story. See the IMCC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IM Cannabis Business Description

Address Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
36GF Score

Get the complete analysis for IMCC

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.14
Price
$1.39
GF Value